Lacosamide 00121-1012-95
- Manufacturer
- Pai Holdings, Llc Dba Pai Pharma
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- August 26, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA216151
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 50 mg/5mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
00121-1012-95Selected1 TRAY in 1 CASE (0121-1012-95) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1012-05)